China Medical Technologies, Inc (in Liquidation) and Others v. Samson Tsang Tak Yung and Others
|
CACV 505/2019 (On appeal from HCA 3391/2016 and [2022] HKCA 427 IN THE HIGH COURT OF THE HONG KONG SPECIAL ADMINISTRATIVE REGION COURT OF APPEAL CIVIL APPEAL NO 505 OF 2019 (ON APPEAL FROM HCA 3391/2016 and 1417/2013 (Consolidated)) ________________________
(Consolidated by Order of Master Chow dated the 23rd day of July 2018) ________________________
____________________ D E C I S I O N ____________________ Hon Chow JA (giving the Decision of the Court): 1.On 19 January 2022, this Court handed down its judgment (“the Judgment”) allowing the Plaintiffs’ appeal against an order made by Ng J (“the Judge”) dated 22 May 2019 whereby the Judge set aside and discharged a worldwide mareva injunction granted ex parte by L Chan J on 11 December 2017, as amended by L Chan J on 8 January 2018 and as continued by Chow J on 12 January 2018 (“the Injunction”), against, inter alia, the 5th and 13th Defendants. The effect of the Judgment is that the Injunction continues against the 5th and 13th Defendants until trial or further order of the court.[1] 2.There are now before the court two applications for leave to appeal. THE 5TH DEFENDANT’S APPLICATION 3.By a Notice of Motion dated 11 February 2022 (“the D5 Notice of Motion”), the 5th Defendant applies for leave to appeal the Judgment to the Court of Final Appeal. The D5 Notice of Motion raises 3 questions said to be questions of great general or public importance which ought to be submitted to the Court of Final Appeal for determination pursuant to s 22(1)(b) of the Hong Kong Court of Final Appeal Ordinance, Cap 484:
4.In addition, the 5th Defendant contends that Questions 1 to 3 above ought to be submitted to the Court of Final Appeal for determination under the “or otherwise” limb of section 22(1)(b) of the Hong Kong Court of Final Appeal Ordinance for the reasons set out in paragraph 5 of the D5 Notice of Motion. 5.We are not satisfied that the 3 questions set out in the D5 Notice of Motion are questions of great general or public importance which ought to be submitted to the Court of Final Appeal for determination. 6.In respect of Question 1, it is premised on a misunderstanding or misconception that the judgment of the Court of Appeal in Convoy has effected some fundamental change in the law relating to the assessment of risk of dissipation of assets for the purpose of an application for a Mareva injunction. The analysis of the Court of Appeal in Convoy was itself based on the judgment of Popplewell J (as he then was) in Fundo Soberano de Angola v dos Santos [2018] EWHC 2199 (Comm) and the judgment of Haddon-Cave LJ in Lakatamia Shipping Co Ltd v Toshiko Morimoto [2019] EWCA Civ 2203. Convoy essentially adopts those English decisions, and explains or elucidates the proper approach that the court should adopt in the assessment of risk of dissipation in cases where a Mareva injunction is sought against a defendant who is accused of fraud or other serious wrongdoings: the court should adopt a holistic approach and take into account all circumstances relevant to the risk of dissipation for the purpose of determining whether a “solid basis for concluding a real risk of unjustified dissipation of assets” by the defendant has been shown (§§34 and 38 of the Judgment). We do not consider that Convoy breaks any new ground. It certainly does not establish that a good arguable case of fraud and/or dishonesty against a defendant “now assumes a greater significance in establishing a real risk of dissipation” as suggested by the 5th Defendant, but affirms (or reaffirms) the position that conduct which may be regarded as being of “low commercial morality” does not necessarily establish risk of dissipation, that being an incorrect, and over-simplified, approach that is sometimes advanced by applicants for a Mareva injunction purportedly in reliance upon Honsaico. 7.Question 2 is not reasonably arguable as a proposition of law and, in any event, does not affect the outcome of this case. The question of whether the relevant time period for assessment of delay should start from (i) the time when the plaintiff ought reasonably to have taken out the Mareva injunction application, or (ii) the time when the defendant had knowledge that the plaintiff might bring a claim against him, depends on the purpose of the inquiry. Delay on the part of an applicant for a Mareva injunction is relevant to the issue of risk of dissipation of assets, and also generally in the court’s consideration of whether it is just and convenient to grant the injunction sought. At §55 of the Judgment, the court accepted Mr Manzoni, SC’s submission that until the Plaintiffs were able to properly formulate their claim in the form of a draft Statement of Claim in around late August 2017 for the purpose of seeking leave to serve out of the jurisdiction, there was no sufficient basis for them to apply for Mareva relief against the Restrained Defendants. This conclusion is based on an assessment of the facts and evidence in the case, and is relevant to the question of whether it was just and convenient to grant the injunction sought by the Plaintiffs in the court’s exercise of its discretion. On the other hand, in relation to the issue of risk of dissipation (which appears to be the focus of Question 2), the crucial question is not when time starts to run in reckoning the Plaintiffs’ delay in making the application for Mareva injunction. As pointed out in the judgment of Lam VP (as he then was) in Convoy, at §78, delay per se would not necessarily bar Mareva relief. The question is still whether the Plaintiffs could show a real risk of dissipation despite delay (§55 of the Judgment). The pertinent inquiry is not when the Plaintiffs could, or should, have made the application, but whether by the time of the application, there was still a sufficient risk of dissipation as to justify the court grating Mareva relief. 8.In respect of Question 3, the so-called “stable-door” point is not an independent issue distinct from the assessment of risk of dissipation. There would not be any different outcome in the present case whether it is treated (i) as a point of reflection of the principle that “equity will not act in vain” and thus no injunction would be granted if the defendant’s assets have already been dissipated, or (ii) as an evidential point that if the defendant has not disposed of his assets despite his knowledge that the plaintiff intends to bring a claim against him, that is a powerful factor militating against the risk of dissipation. In the present case, it has not been suggested that the 5th Defendant has already dissipated all his assets. The evidence indicates that he still has some limited assets which are frozen by the Injunction (§22 of the Judgment). Thus, equity will not be acting in vain here. The court is also satisfied on the facts, notwithstanding the 5th Defendant’s knowledge that the Plaintiffs intended to bring a claim against him, that there is a sufficiently solid basis for concluding that there is a risk of dissipation such that the Injunction ought to be continued against him. Whatever may be the rationale behind the “stable-door” point is not material in the present case. 9.Lastly, it is the settled practice of this court to defer to the Appeal Committee of the Court of Final Appeal in respect of any question as to whether leave to appeal should be granted on the “or otherwise” limb. THE 13TH DEFENDANT’S APPLICATION 10.By a Notice of Motion dated 16 February 2022 (“the D13 Notice of Motion”), the 13th Defendant applies for leave to appeal the Judgment to the Court of Final Appeal. In the D13 Notice of Motion, the 13th Defendant adopts Questions 1 to 3 set out in the D5 Notice of Motion, and add the following Question 4 as being a proposed question of great general or public importance which ought to be submitted to the Court of Final Appeal for determination:
11.We have already dealt with Questions 1 to 3 in the D5 Notice of Motion above and shall not repeat our views here. 12.Question 4 (including the 2 sub-questions) do not raise any distinct question of law of great general or public importance which ought to be submitted to the Court of Final Appeal for determination:
DISPOSITION 13.The applications for leave to appeal are refused, and the 5th and 13th Defendants’ Notices of Motion dated 11 February 2022 and 16 February 2022 respectively are dismissed with costs to the Plaintiffs, to be taxed if not agreed.
Karas LLP, for the Plaintiffs in both actions Mr Martin Ho, instructed by Tony Kan & Co., for the 5thDefendant in HCA 3391/2016 Mr Stewart K M Wong, SC & Ms Elizabeth Cheung, instructed by Eversheds Sutherland, for the 13th Defendant in HCA 3391/2016 [1] For this purpose of this Decision, unless the context indicates otherwise, the expressions and abbreviations as defined in the Judgment shall be adopted. |
Cases cited in this judgment
China Medical Technologies, Inc. (in Liquidation) and Others v. Samson Tsang Tak Yung and Others
China Medical Technologies, Inc (in Liquidation) and Others v. Wu Xiaodong and Others
China Medical Technologies, Inc. (in Liquidation) and Others v. Wu Xiaodong and Others
Skyhigh Investment Ltd v. Yu Jun and Others
Delco Participation B.V. v. Chiho-tiande Group Ltd and Another
Convoy Collateral Ltd v. Cho Kwai Chee (also known as Cho Kwai Chee Roy) and Others
China Medical Technologies, Inc.(in Liquidation) and Others v. Wu Xiaodong and Others
Other judgments that cite this case
Further hearings and rulings under CACV 505/2019